Progressive decline in insulin levels in Rabson-Mendenhall syndrome

被引:43
作者
Longo, N [1 ]
Wang, YH [1 ]
Pasquali, M [1 ]
机构
[1] Emory Univ, Dept Pediat, Div Med Genet, Atlanta, GA 30322 USA
关键词
D O I
10.1210/jc.84.8.2623
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mutations in the insulin receptor gene cause the severe insulin-resistant syndromes leprechaunism and Rabson-Mendenhall syndrome, whose metabolic features include Easting hypoglycemia, postprandial hyperglycemia, and extremely elevated insulin levels. Patients with Rabson-Mendenhall syndrome have a protracted course and eventually develop ketoacidosis. To determine the mechanism causing this progression and the paradoxical fasting hypoglycemia, we conducted a retrospective study in a patient with Rabson-Mendenhall syndrome, who was a compound heterozygous for two missense mutations affecting the kinase domain of the insulin receptor p-subunit (I1115T and R1131W). At birth, the patient had fasting hypoglycemia and postprandial hyperglycemia. This was followed at approximately 3 yr of age by constant hyperglycemia and, at 6 yr of age, by constant ketoacidosis. Urinary organic acids during ketoacidosis resembled those of patients with type 1 diabetes. Plasma glucose levels increased (r(2) = 0.31; P < 0.01), whereas insulin levels decreased with age (r(2) =0.51; P < 0.01). During periods of hypoglycemia and hyperglycemia (0-1 yr of age), constant hyperglycemia (3-4 yr of age), and hyperglycemia with ketoacidosis (6-7 yr of age), insulin levels were significantly correlated with plasma glucose levels (P < 0.05). However, the slope of the regression and the predicted insulin level at zero glucose decreased with increasing age. When insulin levels were normalized for the plasma glucose concentrations, an exponential decrease in the insulin/glucose ratio was observed (r(2) = 0.92; P < 0.01), with most of the decline occurring before 2 yr of age. These results indicate that the paradoxical fasting hypoglycemia of patients with Rabson-Mendenhall syndrome is associated with severely increased levels of circulating insulin and that the progression of this disease is due to a decline in insulin levels.
引用
收藏
页码:2623 / 2629
页数:7
相关论文
共 44 条
[11]   CRYSTAL-STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN-RECEPTOR [J].
HUBBARD, SR ;
WEI, L ;
ELIS, L ;
HENDRICKSON, WA .
NATURE, 1994, 372 (6508) :746-754
[12]   Activating mutations for the Met tyrosine kinase receptor in human cancer [J].
Jeffers, M ;
Schmidt, L ;
Nakaigawa, N ;
Webb, CP ;
Weirich, G ;
Kishida, T ;
Zbar, B ;
VandeWoude, GF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) :11445-11450
[13]   Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality [J].
Joshi, RL ;
Lamothe, B ;
Cordonnier, N ;
Mesbah, K ;
Monthioux, E ;
Jami, J ;
Bucchini, D .
EMBO JOURNAL, 1996, 15 (07) :1542-1547
[14]   Type 2 diabetes - who is conducting the orchestra? [J].
Kahn, BB ;
Rossetti, L .
NATURE GENETICS, 1998, 20 (03) :223-225
[15]   Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance [J].
Kahn, BB .
CELL, 1998, 92 (05) :593-596
[16]  
KISHIMOTO M, 1994, J BIOL CHEM, V269, P11349
[17]   FLUCTUATION OF INSULIN RESISTANCE IN A LEPRECHAUN WITH A PRIMARY DEFECT IN INSULIN BINDING [J].
KOBAYASHI, M ;
TAKATA, Y ;
SASAOKA, T ;
SHIGETA, Y ;
GOJI, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (05) :1084-1088
[18]   Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin - Evidence that IRS-1 phosphorylation is not sufficient for normal insulin action [J].
Krook, A ;
Moller, DE ;
Dib, K ;
ORahilly, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (12) :7134-7140
[19]   Functional activation of mutant human insulin receptor by monoclonal antibody [J].
Krook, A ;
Soos, MA ;
Kumar, S ;
Siddle, K ;
ORahilly, S .
LANCET, 1996, 347 (9015) :1586-1590
[20]   Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes [J].
Kulkarni, RN ;
Brüning, JC ;
Winnay, JN ;
Postic, C ;
Magnuson, MA ;
Kahn, CR .
CELL, 1999, 96 (03) :329-339